Cancer Biomarker Market Size, Share and Growth Forecast by Regions 2020-2025

Felton, Calif., USA, Dec. 01, 2020 — /EPR Network/ —

Global Cancer Biomarker Market is anticipated to reach USD 33.7 billion by 2025. Biomarkers imply the molecules or substances found in tissues, blood, or the other body fluid; which states the abnormal and normal condition of the body. The cancer biomarkers tests are conducted to detect mutated or normal genes responsible for cancer.

The factors that propel the growth of the cancer biomarker industry include advancements in omics technologies, prevalence of cancer, growth in R&D funding from private bodies and government, rising healthcare spending, and increasing demand for personalized medicine in cancer treatments. On the other hand, there are factors that may hamper the growth of the market including reimbursement issues, need for immediate processing, and high cost of diagnosis. Cancer Biomarker Market is anticipated to grow at a significant CAGR of 14.3% in the upcoming period as the scope, product types, and its applications are increasing across the globe.

Access Cancer Biomarker Market Report with TOC @ https://www.millioninsights.com/industry-reports/cancer-biomarker-market

Cancer Biomarker Type Outlook (Revenue, USD Billion, 2014 – 2025)

  • Breast cancer
  • Prostate cancer
  • Colorectal cancer
  • Cervical cancer
  • Liver cancer
  • Lung cancer
  • Others

Cancer Biomarker Biomolecule Outlook (Revenue, USD Billion, 2014 – 2025)

  • Genetic Biomarkers
  • Epigenetic Biomarkers
  • Metabolic Biomarkers
  • Proteomic Biomarkers
  • Others

Cancer Biomarker Application Outlook (Revenue, USD Billion, 2014 – 2025)

  • Drug discovery and Development
  • Diagnostics
  • Personalized medicine
  • Others

Some of the key players that fuel the growth of the cancer biomarker industry comprise F-Hoffmann-La Roche Ltd.; Abbott Laboratories; Thermo Fisher Scientific Inc.; QIAGEN; Affymetrix Inc.; Agilent Technologies; Illumina, Inc.; Merck & Co. Inc.; Sino Biological Inc.; Hologic, Inc.; Dickinson and Company, and Becton. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.

Request a Sample Copy of Cancer Biomarker Market Report @ https://www.millioninsights.com/industry-reports/cancer-biomarker-market/request-sample

Cancer Biomarker Regional Outlook (Revenue, USD Billion, 2014 – 2025)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • Asia Pacific
  • China
  • Japan
  • Latin America
  • Mexico
  • Brazil
  • MEA
  • South Africa

Visit Our Blog: https://marketreportsassistance.wordpress.com

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email: ryan@millioninsights.com

Million Insights

Office No. 302, 3rd Floor, Manikchand Galleria,

Model Colony, Shivaji Nagar, Pune, MH, 411016 India

Phone: 91-20-65300184

Email: sales@millioninsights.com

 

Matched content

Editor’s pick

Express Press Release Distribution
The entire EPR Network is up for sale!
This is default text for notification bar